TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,302,460 | -2.1% | 83,491 | -11.9% | 0.18% | -17.5% |
| Q2 2022 | $1,330,000 | +277.8% | 94,747 | +285.8% | 0.22% | +265.6% |
| Q1 2022 | $352,000 | +4.5% | 24,556 | -1.1% | 0.06% | +190.5% |
| Q4 2021 | $337,000 | -44.8% | 24,820 | -31.6% | 0.02% | -80.2% |
| Q2 2021 | $610,000 | -17.0% | 36,261 | -9.9% | 0.11% | +9.3% |
| Q1 2021 | $735,000 | -75.5% | 40,250 | -75.9% | 0.10% | -74.7% |
| Q2 2020 | $2,996,000 | +501.6% | 167,092 | +409.5% | 0.38% | +481.8% |
| Q1 2020 | $498,000 | +3.8% | 32,796 | +34.8% | 0.07% | -16.5% |
| Q4 2019 | $480,000 | – | 24,328 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |